MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2)

Investigator: David Chiu, MD

Study Coordinator:

Status: Enrolling Number: NCT03545607


Protocol Number: Pro00019190


A Phase 3 study to examine the safety and effectiveness of the allogeneic, adult stem cell investigational product, MultiStem, in adults who have suffered an acute ischemic stroke in the previous 18-36 hours.
More to Explore